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Introduction. Although it is well known that BMP-2 and BMP-7 play signiﬁcant roles in cartilage metabolism, data about intra-
articular expression and localization of these proteins and their receptors in humans are rare. Methods. Biopsies of synovia and
debrided cartilage were taken in patients undergoing autologous chondrocyte implantation. Expression of BMP-2, BMP-7, and
their receptors BMPR-1A, BMPR-1B and BMPR-2 were semiquantitatively evaluated by immunohistological staining. Results.
BMP-7 was equally highly expressed in all cartilage and synovial biopsies. Increased levels of BMPR-1A, but not of BMPR-1B,
and BMPR-2, were found in all synovial and 47% of all cartilage samples (P = 0.002). BMP-2 was positively scored in 47% of
all cartilage and 40% of all synovial specimens. Defect size, KOSS, Henderson or Kellgren-Lawrence score did not statistically
signiﬁcant correlate with the expression of the analyzed proteins or Mankin and Pritzker scores. Duration of symptoms and
localization of lesions were associated with KOSS (P<0.02), but there was no inﬂuence of these parameters on protein expression.
Conclusions. BMP-2, BMP-7, and BMPR-1A were expressed in cartilage and synovia of knees with focal cartilage lesions. Although
defect localization and duration of symptoms decisively inﬂuence KOSS, there was no associated alteration of protein expression
observed.
1.Introduction
BMPs belong to the transforming growth factor-beta (TGF-
β) superfamily, consisting of the diﬀerent forms of TGF-β,
and other growth diﬀerentiation or neurotrophic factors [1].
Eﬀects of BMP-2 and BMP-7 are numerous, for example,
they play a signiﬁcant role in skeletal development [2]
and are potent inducers of bone formation [3]. Therefore,
several years ago both proteins gained their registration
approval as pharmaceuticals to treat delayed fracture healing
or spinal fusions. BMP-2 is able to promote chondrogenesis
in human mesenchymal stem cells [4], in which the TGF-β-
driven tendency to develop cartilage hypertrophy is partially
inhibited. The ability of BMP-2 to induce chondrogenesis
has been demonstrated in diﬀerent experimental set-ups
[5]. BMP-2 coating of scaﬀolds resulted in mature cartilage
formation using either mesenchymal stem cells or ampliﬁed
chondrocytes [6]. Furthermore, mechanical stress was found
to upregulate BMP-2 as well as BMP-2 signaling in human
cartilage explants [7], indicating a role for BMP-2 in natural
cartilage reparative processes. BMP-7 is also known as
osteogenic protein-1 (OP-1) and exhibits characteristics as
an anabolic factor in cartilage metabolism. BMP-7 was able
to enhance synthesis of extracellular matrix components
and to promote cartilage repair. This could be shown for
both articular and disc cartilage applications [8]. BMP-7
and its receptors have been immunohistologically identiﬁed
in rabbit articular cartilage and bone, suggesting a possible
role in cartilage and bone homeostasis [9]. BMP-7 was also
detected in human articular chondrocytes showing diﬀeren-
tial regulation in normal and osteoarthritic cartilage [10].
BMP eﬀects are mediated by type 1 and type 2 receptors,2 The Scientiﬁc World Journal
which act as intrinsic serine- and threonine kinases. BMP
receptors usually form active dimers and signal via the
downstream molecules Smad1, 5, and 8. Three type 1
receptors (BMPR-1A or ALK-3, ActR-1A or ALK-2, and
BMPR-1B or ALK-6) and three type 2 receptors (BMPR-2,
ActR-2, and ActR-2B) are discriminated, but only BMPR-
1A, 1B, and 2 are speciﬁc to BMPs [11]. The signaling is
highly regulated at diﬀerent molecular levels, for example,
Noggin blocks BMP signaling and Smad6 prevents acti-
vation of Smad1, 5, and 8. Therefore, overexpression of
noggin in mature osteoblasts causes osteoporosis in mice
[12] and overexpression of Smad6 in chondrocytes causes
delays in chondrocyte diﬀerentiation and maturation [13].
Smad4 serves as an exclusive coactivating smad that elicits
most of the transcription responses invoked by the TGF-
β superfamily members, deletion of Smad4 also leads to
defective chondrocyte maturation [14]. Recently, the role for
BMP-2insurgicallyinducedcartilagerepairwasemphasized,
since it has been shown that synovial expression correlated
with the clinical outcome after 1 year [15]. Although other
proteins with known roles in cartilage metabolism as bFGF,
IGF-I, or BMP-7 were present in lavage ﬂuids of knee joints
[16], neither of these cytokines was statistically signiﬁcant
associated with IKDC score following 1 year. Data of this
studywasbasedonanalysesofperioperativelavagesofknees,
but it remained unclear where BMPs are located and what
clinical parameters may inﬂuence BMP-2 or BMP-7 expres-
sion.Thisstudywasinitiatedinordertoanswerthisquestion
and to further clarify localizations of the receptors BMPR-
1A, BMPR-1B, and BMPR-2. Several radiological scores have
been established in order to deﬁne progress of osteoarthritis
(OA) as the Kellgren-Lawrence score [17] for conventional
radiographies or the KOSS score for magnetic resonance
imaging (MRI) [18]. Since we hypothesized a correlation
of BMP expression and their receptors with OA, a possible
association between the mentioned radiographic scores
and immunohistologically determined BMP expression was
examined.
2.MaterialandMethods
2.1. Study Design. 15 patients were enrolled in a prospective
clinical trial between 01.01.2010 and 30.06.2010. Selection of
patients followed the criteria as deﬁned beneath.
Inclusion criteria were the performance of an autologous
chondrocyte implantation (ACI) of the knee joint because of
full thickness cartilage lesions graded III and IV according
to ICRS classiﬁcation [19]o fv a r i o u ss i z e ,a g r e e m e n tt o
participate in the study, age >17 years, and <66 years (as
recommended [20]).
Exclusion criteria were alcohol or drug abuse, mental re-
tardation with incapability to complete the necessary self-
reports, joint eﬀusion >30mL, persistent knee instability,
and infection.
The study was approved by the ethical board of the Uni-
versity of Freiburg (AN-EK-FRBRG-64/10, study number
DRKS00000487). An informed consent was obtained from
every subject included in the study.
Besides histological data, the following parameters were
collected: epidemiological characteristics, defect size (cm2),
duration of symptoms (months), Knee Osteoarthritis Scor-
ing System (KOSS) for evaluation of OA progress in pre-
operative magnetic resonance images (MRI) as described in
[18], Henderson score for evaluation of subchondral edema
as described in [21], Kellgren-Lawrence score as described in
[22].
2.2. Specimen Collection. The ACI surgical technique has
been well deﬁned in numerous publications [20, 23, 24].
Implantation consists of arthrotomy and defect preparation
without aﬀecting the subchondral bone layer. This includes
debridement of the repair or defect cartilage zone, gaining
sharp edges of healthy adjacent cartilage in order to realize
a proper containment. The removed cartilage debris was
collected and kept in formalin for later histological analysis.
Furthermore, a biopsy of synovia out of the arthrotomy
region was taken and separately preserved in formalin.
2.3. Grading of Cartilage Lesion. The amount of chondral
damage was graded from 0 to 4 based on the ICRS classiﬁca-
tion [19]. Grade 0 represents normal articular cartilage and
grade I shows superﬁcial lesions as soft indentation and/or
superﬁcial ﬁssures and cracks. A grade II defect is a partial-
thickness defect; it features lesions extending down to less
than 50% of cartilage depth. With grade III defects, there
are cartilage defects extending down to more than 50% of
cartilage depth as well as down to the calciﬁed layer, and
down to but not through the subchondral bone. Blisters are
included in this grade. In grade IV injuries, the subchondral
bone is involved. Decision about grading of the cartilage
lesion was intraoperatively done, when the surgeon debrided
the defect zone.
2.4. Histology. Specimen were ﬁxed in 4% paraformaldehyde
and dehydrated in graded series of ethanol. Samples were
embedded in paraﬃna n dc u t( 3μm) on a Leica RM 2255.
Sections were incubated in alcian blue solution or hema-
toxylin and subsequently eosin as previously described [25].
The slides were washed, dried at room temperature, and
coverslips were mounted with Roti-Histokitt II mounting
media.
2.5. Immunohistology. All used antibodies (AB) were puri-
ﬁedIgGisotypeABandtestedforimmunohistologicalappli-
cations with human epitopes by all manufacturers. As con-
trol tissue small intestine, kidney, placenta, or cartilage was
used. Stainings were done using an Autostainer Plus S3400
(DAKO, Hamburg, Germany) with the appropriate controls
for each run. Sections were ﬁxed in 4% paraformaldehyde,
dehydrated, embedded in paraﬃn, and cut in 2μm slices.
Before incubation with primary antibodies, antigens were
unmasked using the indicated method (Table 1). For im-
munostaining a Dako REAL Detection System (Alkaline
Phosphatase/RED, Rabbit/Mouse, K5005) was used accord-
ing to the manufacturer’s instructions (DAKO, Hamburg,
Germany). Brieﬂy, primary antibodies were applied usingThe Scientiﬁc World Journal 3
Table 1: Speciﬁcation of the used antibodies for immunohistology.
Antibody BMP-2 BMP-7 BMPR-1A BMPR-1B BMPR-2
Speciﬁcation Mouse, monoclonal Rabbit, polyclonal Rabbit, polyclonal Mouse, monoclonal Rabbit, polyclonal
Dilution 1:200 1:200 1:25 1:200 1:50
Procedure for protein
unmasking
Proteinase K (Dako
REAL Proteinase K,
Hamburg, Germany)
Proteinase K
(Dako REAL
Proteinase K,
Hamburg, Germany)
Heat-induced antigen
unmasking
Heat-induced antigen
unmasking
Proteinase K (Dako
REAL Proteinase K,
Hamburg, Germany)
Manufacturer and
product number
Abcam, ab6285,
Cambridge, UK
Abcam, ab56023,
Cambridge, UK
Lifespan Biosciences,
LS-C4217, Seattle,
USA
Abcam, ab78417,
Cambridge, UK
Sigma, HPA017385,
St. Louis, USA
the indicated dilution (Table 1). Antibody diluent (ZUC
025-500, Zytomed Systems, Berlin, Germany) was used for
all preparations. After washing with Dako Wash Buﬀer (S
3006), REAL biotinylated secondary antibodies (AB2) were
applied at a 1:100 dilution. After washing, Dako REAL
Streptavidin Alkaline Phosphatase was applied followed by
the RED chromogens 1–3. In order to inhibit endogenous
alkaline phosphatase activity, Dako REAL Levamisole was
added to the substrate. For controls, the primary antibody
wasreplacedbyeithernormalserum,thesecondaryantibody
was applied alone, or control tissue was used. Finally, slides
were counterstained with haematoxylin.
2.6. Evaluation of Slides and Radiographs. Immunostainings
or radiographs were assessed by two independent referees.
In case of disagreement, a consensus evaluation was found
with support of a third referee. Intensity (0–4) of staining
and percentage of stained cells (1–3) were estimated and a
summary score was calculated. Since staining of the diﬀerent
regions partially showed varying intensity, areas with the
least strength were regularly used for scoring. General
histological stainings were used to determine Mankin score
[26], Pritzker (OARSI) score [27], and Krenn score [28]. The
KOSS score was used for quantitative evaluation of OA signs
in MRI [18], the Kellgren-Lawrence score [17]f o rc o n v e n -
tional radiographies.
2.7. Statistics. A l lv a l u e sw e r ee x p r e s s e da sm e a n± standard
deviation. Data sets were compared with the rank sum
U-Test (Mann-Whitney). Signiﬁcance of correlations was
determined by calculating the Spearmen (Rho) coeﬃcient.
Categorical data are presented as absolute frequency. Data
(incidences) were arranged in cross tables, and statistical
signiﬁcance of diﬀerences calculated using the 2-tailed Fisher
exact test. Statistical signiﬁcance was deﬁned when P<0.05.
3. Results
3.1. Study Parameters. T h ea v e r a g ea g eo fa l li n c l u d e d
patients(15)was33.12 ±11.11years,thegenderdistribution
was9/6male/femaleindividuals.Theretropatellarregionwas
aﬀected 6 times, the medial femoral condyle 8 times. Once
the trochlea was aﬀected in combination with the lateral
femoral condyle. The ACI was performed alone in 5 cases;
otherwise transplantation was supplemented by correction
of leg axis (4), soft tissue balancing measures for the patella
(4), replacement of the anterior cruciate ligament (1), or
bone grafting (1). The average defect size was 3.83 ±
1.48cm2. In only 3 cases ACI was the ﬁrst operation of the
knee,intheothercasesACIwaspreceded7timesbycartilage
regenerating surgery as microfracturing, 4 times by partial
meniscus resections, once by a correction of leg axis, once by
patella balancing, and once by removal of free joint bodies
(multiple nominations per patient possible, 14 operational
measures in 12 patients). The preoperative ICRS score was 3
in 7 cases and 4 in 8 cases. An MRI and a conventional X-ray
of the aﬀected knee made within 180 days before the opera-
tionwerea vailableinallpatients.ThemeanK OSSwas7.13±
2.13, the mean Kellgren-Lawrence score was 0.93 ± 0.70.
Average preoperative duration of complains was 51.73 ±
33.95 months [6-120].
3.2. Immunohistological Analysis of BMP-2, BMP-7, BMPR-
1A, BMPR-1B, and BMPR 2 Expression. BMP-7 was highly
expressed in all cartilage and synovial biopsies, sum of scores
reached 90 points, the maximum of possible points. Positive
staining of BMPR-1B and BMPR-2 was only sporadically
foundwithoutanincreaseofthesemiquantitativescoresover
background levels (sum score 15 points, the minimum of
possible points, in synovial and cartilage for both proteins).
BMP-2 was positively scored in 47% of all cartilage (sum
score 35 points) and 40% of all synovial specimens (sum
score 35 points). Increased levels of BMPR-1A were found
in all synovial samples (sum score 73 points), but only in
47%ofallcartilagebiopsies(sumscore39points).BMPR-1A
was the only investigated protein with statistically signiﬁcant
diﬀerent expression in cartilage and synovia (P = 0.002).
Expression of BMP-7 was statistically signiﬁcant higher in
synovia compared to BMP-2 (P<0.001), BMPR-1A (P =
0.0002), BMPR-1B (P<0.001), and BMPR-2 (P<0.001).
Expression of BMP-7 was statistically signiﬁcant higher in
cartilage compared to BMP-2 (P<0.001), BMPR-1A (P<
0.001), BMPR-1B (P<0.001), and BMPR-2 (P<0.001).
Expression of BMPR-1A in synovia (P<0.0001) and
cartilage (P = 0.003) was statistically higher compared to
BMPR-1B and BMPR-2. BMPR-1A-expression in synovia
scored higher than BMP-2 (P = 0.0015), but was not
diﬀerent in cartilage (P = 0.7863). An overview about
the summary scores is given in Figure 1. Figure 2 shows4 The Scientiﬁc World Journal
Table 2: Correlation matrix.
Defect size KOSS (MRI) Henderson score Kellgren-Lawrence score Duration (months) Krenn score
Defect size
Corr. coeﬃcient 1.0000 0.6259 0.1567 0.4705 0.1478 −0.2382
Valid cases 15 15 15 15 15 15
Signiﬁcance (P) 0.0000 0.0063∗ 0.2886 0.0384∗ 0.2995 0.1963
KOSS (MRI)
Corr. coeﬃcient 0.6259 1.0000 0.6133 0.2468 0.6272 −0.1165
Valid cases 15 15 15 15 15 15
Signiﬁcance (P) 0.0063∗ 0.0000 0.0075∗ 0.1876 0.0062∗ 0.3397
Henderson score
Corr. coeﬃcient 0.1567 0.6133 1.0000 −0.2089 0.3768 −0.4605
Valid cases 15 15 15 15 15 15
Signiﬁcance (P) 0.2886 0.0075∗ 0.0000 0.2274 0.0831 0.0421∗
Kellgren-Lawrence score
Corr. coeﬃcient 0.4705 0.2468 −0.2089 1.0000 −0.3197 0.0330
Valid cases 15 15 15 15 15 15
Signiﬁcance (P) 0.0384∗ 0.1876 0.2274 0.0000 0.1227 0.4536
Duration of symptoms (months)
Corr. coeﬃcient 0.1478 0.6272 0.3768 −0.3197 1.0000 0.1238
Valid cases 15 15 15 15 15 15
Signiﬁcance (P) 0.2995 0.0062∗ 0.0831 0.1227 0.0000 0.3301
Krenn score (synovitis)
Corr. coeﬃcient −0.2382 −0.1165 −0.4605 0.0330 0.1238 1.0000
Valid cases 15 15 15 15 15 15
Signiﬁcance (P) 0.1963 0.3397 0.0421∗ 0.4536 0.3301 0.0000
∗P< 0.05, corr. coeﬃcient: correlation coeﬃcient (Spearman-Rho), Syn: synovia, C: cartilage.
representative immunohistological stainings of cartilage,
Figure 3 of synovia.
3.3. Correlation Analysis of Radiographic Scores, Clinical, and
Histological Parameters. The parameters defect size, KOSS
score (grading of OA in MRI), Henderson score (subchon-
dral edema), Kellgren-Lawrence score (grading of OA in
conventionalradiographs),durationofsymptoms(months),
and Krenn score (grading of synovitis) were correlated with
eachotherinordertoelucidatepossibleassociationsbetween
clinical symptoms and morphological changes visible in
diﬀerent imaging techniques. Defect size was statistically
signiﬁcant associated with KOSS score (Rho = 0.6259,
P = 0.0063) and Kellgren-Lawrence score (Rho = 0.4705,
P = 0.0384). KOSS score was further highly statistically
signiﬁcant associated with Henderson score (Rho = 0.6133,
P = 0.0075), which is not surprising, because grading of
edema is part of the KOSS score. Interestingly, KOSS score
statistically signiﬁcant correlated with duration of symptoms
(Rho = 0.6272, P = 0.0062), that appears the only associa-
tion between imaging and symptoms. Data are summarized
inTable 2.Furthermore,defectsizes,KOSSscore,Henderson
and Kellgren-Lawrence score were analyzed for their possible
association with the expression of BMPR-1A and BMP-2.
There was no statistically signiﬁcant correlation of these
parameters with the expression of the analyzed proteins or
Mankin and Pritzker score. BMP-7, BMPR-1B, and BMPR-2
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Quantitation of BMP-2, BMP-7, and their receptors
in cartilage and synovia
Figure 1: Quantitation of BMP-2, BMP-7, and their receptors in
cartilage and synovia.
did not show alterations between diﬀerent patients and were
excluded for this analysis.The Scientiﬁc World Journal 5
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Figure 2: Immunostaining of cartilage, (a) BMPR-1A (summary score 6), (b) BMPR-1B (summary score 1), (c) BMPR-2 (summary score
1), (d) BMP-7 (summary score 6), (e) BMP-2 (summary score 4).
3.4.AnalysisoftheInﬂuenceofDurationofSymptoms. Corre-
lation analysis (Table 2) revealed that duration of symptoms
appeared as a critical factor. Therefore, the possible inﬂuence
on the other study parameters was evaluated. At ﬁrst the
critical time period for the signiﬁcance was calculated. When
dividing the individuals in two groups with ≤48 months and
>48 months of complains, the number of patients in each
group was almost equal and mean KOSS scores statistically
signiﬁcant diﬀered (P = 0.0202). All other parameters
including OA and immunohistological scores did not show
anystatisticalsigniﬁcantdiﬀerenceassummarizedinTable 3.
Only the summary scores of BMPR-1A and BMP-2 were
integrated in the analysis, because scores of BMP-7, BMPR-
1B, and BMPR-2 did not show alterations between diﬀerent
patients.
3.5. Analysis of the Inﬂuence of Localizations of Chondro-
malacia. Since localizations of chondromalacia (CM) has
previously been described as a critical factor for long-term
prognosis following treatment of cartilage defects [29], this
parameter was evaluated in this study with regard to a pos-
sible diﬀerent expression of BMPR-1A and BMP-2. Because
scoresofBMP-7,BMPR-1B,andBMPR-2didnotshowalter-
ations between diﬀerent patients these scores were excluded.
6 patients with retropatellar CM were compared with 8
patients withCM of the medial femoralcondyle. One patient
with multiple localizations was excluded from this analysis.
Subchondral bone layer was more frequently aﬀected in the
group with CM of the medial femoral condyle (ICRS score
3.75 ± 0.46 versus 3.17 ± 0.41, P = 0.0374), and KOSS score
was higher in this group (8.12 ± 2.17 versus 5.5 ± 0.87, P =
0.0201). Although both parameters indicate the presence
Table 3: Comparison between patients with diﬀerent durations of
complains (≤48 months n = 7, >48 months n = 8).
Criterion
Duration of
symptoms Signiﬁcance (P)
≤48 months >48 months
Age 39.22 ± 12.39 27.78 ± 6.732 0.0638∗
Gender (f/m) 3/8 3/1 0.7552#
ICRS score 3.43 ± 0.53 3.62 ± 0.52 0.4623∗
Defect size 3.68 ± 1.34 3.97 ± 1.67 0.4437∗
KOSS (MRI) 5.86 ± 1.57 8.25 ± 1.98 0.0202∗
Henderson score 2.00 ± 0.82 2.87 ± 1.36 0.1697∗
Kellgren-Lawrence
score 1.00 ± 0.58 0.87 ± 0.83 0.7023∗
Duration of
symptoms
(months)
23.43 ± 16.36 76.50 ± 23.95 0.0010∗
Krenn score 2.00 ± 1.41 2.25 ± 1.03 0.5048∗
BMP-2-Syn 2.28 ± 1.89 2.37 ± 2.06 1.0000∗
BMP-2-C 2.43 ± 1.90 2.25 ± 1.58 0.9500∗
BMPR-1A-Syn 5.00 ± 1.00 4.75 ± 0.89 0.6171∗
BMPR-1A-C 2.57 ± 1.62 2.62 ± 2.37 0.9000∗
Mankin score 8.00 ± 2.00 7.375 ± 3.02 0.8590∗
Pritzker score 3.43 ± 0.79 3.62 ± 1.51 0.9497∗
∗U-Test (Mann-Whitney), #Fisher exact test, f: female, m: male, Syn:
synovia, C: cartilage.
of more severe cartilage lesions in the group with CM of
the medial femoral condyle, there were no further statisti-
cally signiﬁcant diﬀerences between both groups, especially
with regard to immunohistological and OA scores. Data are
summarized in Table 4.6 The Scientiﬁc World Journal
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Figure 3: Immunostaining of synovia, positive staining (arrows) is indicated by the red color mainly located around the nucleus of
chondrocytes, (a) BMPR-1A (summary score 6), (b) BMPR-1B (summary score 1), (c) BMPR-2 (summary score 1), (d) BMP-7 (summary
score 6), (e) BMP-2 (summary score 2).
4. Discussion
4.1. BMP and Receptor Expression. The potential role for
BMP-7 in cartilage repair has been demonstrated in various
in vitro studies [8, 11, 30], showing BMP-7 induced proan-
abolicactivityandelevatedproductionofECMcomponents.
Encouraged by this success, several in vivo studies and trials
in humans have been undertaken that have conﬁrmed a
crucialroleforBMP-7incartilagemetabolismandOAdevel-
opment. For example a recent gene-array analysis revealed
that BMP-7 is involved in the regulation of numerous key
cytokines responsible for cartilage matrix production and
modulation, and other anabolic or catabolic pathways in
cartilage homeostasis as TGF-β/BMPs, IGF, and VEGF [31].
Even a phase 1 safety and tolerability study of BMP-7
application in symptomatic knee OA was initiated, suggest-
ing a symptom response to the BMP-7 treatment together
with a lack of dose limiting toxicity [32]. The intra-articular
concentrations of BMP-7 in knee joints vary depending on
thedegreeofCM[16].Inaddition,amountsofplasmaBMP-
7 seem to show a positive correlation with synovial ﬂuid
BMP-7 levels, approving the potential role in cartilage repair
and OA development [33]. A central question of the intro-
duced study was to gain data about the localization of the
BMPs and their receptors comparing expression in synovia
and cartilage close to cartilage repair zones. A previously
published study has already shown that human articular
chondrocytes express BMP-7 with distinct patterns and
correlations to its pro-form [10]. This could be conﬁrmed
by our results demonstrating strong BMP-7 expression in
normal cartilage and bordering repair regions. Furthermore,
intense BMP-7 signals were found in the synovia. Besides
BMP-7 other members of the TGFβ superfamily as BMP-
3, CDMP-1, and CDMP-2 were detected in all layers of
normal articular cartilage with the strongest expression in
chondrocytes of the transitional layer [34]. Similar to BMP-7
a strong body of evidence indicates a crucial role for BMP-
2 in natural and surgically induced cartilage repair [15]. For
example, it has been shown that exogenous BMP-2 dramati-
cally improved the chondrogenic character of ampliﬁed knee
articular chondrocytes over two passages, as assessed by type
II procollagen expression and synthesis [35]. A supposed
basis of surgically induced cartilage repair is the recruitment
and chondrogenic diﬀerentiation of mesenchymal stem cells
(MSCs). Several studies have recently shown that BMP-2
applied together with TGFβ1 or IGF-1 was able to induceThe Scientiﬁc World Journal 7
Table 4: Comparison between patients with diﬀerent localizations
of chondromalacia (retropatellar n = 6 or medial femoral condyle
n = 8).
Criterion
Medial
femoral
condyle
Retropatellar Signiﬁcance
(P)
Age 30.73 ± 10.85 35.49 ± 12.64 0.6982∗
Gender (f/m) 2/3 3/5 0.9999#
ICRS score 3.75 ± 0.46 3.17 ± 0.41 0.0374∗
Defect size 4.09 ± 1.79 3.29 ± 0.94 0.1882∗
KOSS (MRI) 8.12 ± 2.17 5.5 ± 0.87 0.0201∗
Henderson score 2.87 ± 1.36 2.00 ± 0.89 0.1826∗
Kellgren-Lawrence
score 0.75 ± 0.89 1.00 ± 0.00 0.3838∗
Duration of
symptoms (months) 65.25 ± 37.84 32.33 ± 21.55 0.0515∗
Krenn score 2.25 ± 1.28 2.00 ± 1.26 0.6836∗
BMP-2-Syn 2.62 ± 2.26 2.17 ± 1.60 0.9427∗
BMP-2-C 2.00 ± 1.19 2.33 ± 2.06 1.000∗
BMPR-1A-Syn 5.25 ± 0.89 4.50 ± 0.84 0.1279∗
BMPR-1A-C 2.50 ± 2.26 2.50 ± 1.76 0.8860∗
Mankin score 8.00 ± 3.34 7.67 ± 0.82 0.8943∗
Pritzker score 4.00 ± 1.41 3.17 ± 0.41 0.2810∗
∗U-Test (Mann-Whitney), #Fisher exact test, f: female, m: male, Syn:
synovia, C: cartilage.
a stable chondrogenic phenotype in MSCs of diﬀerent ori-
gins [4, 36]. Data of these studies together with the presented
results, showing expression of BMP-2 in cartilage close to
repair zones and in synovia of knees with circumscribed
cartilage lesions, suggest a potential key role for BMP-2 in
these regenerating processes. In a previously published study
it could be shown that BMP-2 is more consistent expressed
in knee joints with local CM compared to BMP-7 [15]. Fur-
thermore,BMP-2-butnotBMP-7levelswereassociatedwith
a better clinical outcome. Immunostainings now seemed to
demonstrate an opposite result. But there are several things
to take into account. At ﬁrst it has to be considered that
only the worst regions with the lowest intensity or quantity
of expression were evaluated. This had to be done, because
partially normal cartilage was debrided at the edge of the
biopsy. Considering this, it may be concluded that BMP-2-
expression was more dependent on cartilage diﬀerentiation
than expression of BMP-7, because BMP-7 scores were
equally high in all samples and BMP-2 scores varied. Similar
to our results, showing BMPR-IA expression in cartilage
of human knees with focal CM, another study conﬁrmed
BMPR-IA expression in both normal and osteoarthritic
articular cartilage. Data for BMPR-IB were also comparable
demonstrating the lack of staining in OA cartilage [34]. This
is slightly diﬀerent to a study in rabbits; here BMPR-1B
displayedthestrongeststainingoftheBMP-receptorsinboth
cartilage and bone, but BMPR-1A was also expressed in
normal cartilage but not in calciﬁed layers [9]. Taken
together, all data suggest that not only BMP-2 or BMP-7
are expressed in cartilage but also their receptors with
diﬀerent intensity and quantity dependent on the species,
and the diﬀerent antibodies or staining protocols. Although
there are some studies suggesting that BMP-2 signiﬁcantly
promoted the TGFβ-induced chondrogenic diﬀerentiation
of synovium-derived stem cells in vitro [37], data about
expression of BMPs and their receptors in the synovia of
knees with focal CM are still missing. Our results indicate
that concentrations of BMP-2, BMP-7, and their receptors
BMPR-1A, -1B, and -2 are similar in synovia and cartilage.
This association is supported by experimental data gained
during research in rheumatoid arthritis (RA). BMP signaling
ligands were determined in synovium and cartilage extracts
of arthritic knees with comparable activity, showing also
downregulation of BMP-7 by inﬂammation-induced TNFα
[38].
4.2. MRI, Clinical Parameters and Histology. MRI in associa-
tion with quantitative image analysis enables the acquisition
of quantitative information on articular cartilage physiology,
pathophysiology and degenerative changes in OA [39, 40].
Immunohistological assessment of the expression of BMPs
and their receptors was expected to be similarly associated
with OA development; however, our data clearly show that
a statistical correlation of histological data and quantitative
radiographyismissing.Apparentreasonsarethefocalnature
of CM present in the evaluated population, and the weak
associationofBMPexpressionwiththeoverallchangesinthe
knee joint during OA development. KOSS score statistically
signiﬁcant correlated with duration of symptoms, which
probablysimplydocumentstheprogressionofOAassociated
joint changes with time. This is also mirrored by the phe-
nomenon of a better clinical outcome following microfrac-
ture treatment for focal cartilage lesions in patients with
a history of knee complains less than 12 months before
treatment [41].
4.3. Localization and Duration. A previously published
review summarized the factors possibly inﬂuencing the clin-
ical outcome after cartilage regeneration by microfracturing.
Although it could be shown that age <40 years, duration
of symptoms <12 months, lesion size <4cm 2,b o d ym a s s
index <30kg/m2, preoperative Tegner score (activity level)
>4, and no previous surgery seemed to positively inﬂuence
the outcome, the authors were not able to evaluate the
eﬀect of localization of chondromalacia [42]. Other studies
suggested that the best results in treatment of circumscribed
cartilage lesions are found in young patients with defects
on the femoral condyles [29]. These data let us evaluate the
possible inﬂuence of defect localization on BMP expression.
The subchondral bone layer was more frequently aﬀected in
the group with CM of the medial femoral condyle, and KOSS
score was higher in this group. Although both parameters
indicate the presence of more severe cartilage lesions in the
group with CM of the medial femoral condyle, there were
no further statistically signiﬁcant diﬀerences between both
groups, especially with regard to immunohistological and
OA scores.8 The Scientiﬁc World Journal
4.4. Conclusion. Summarizing, BMP-7 was consistently ex-
pressed in cartilage and synovial biopsies of patients under-
goingACIbecauseofcircumscribedcartilagelesions.BMPR-
1A and BMP-2 were also found in a signiﬁcant number of
cases, but data indicate a stronger modulation of expression
by the degree of CM. Although duration of symptoms sta-
tistically signiﬁcant correlated with KOSS score, describing
progress of OA in MRI by quantitative imaging, there was no
inﬂuence of this parameter on protein expression. Although
several scores indicate a more severe degree of CM in defects
of the medial condyles compared to retropatellar damages,
localization did not inﬂuence immunohistologically quanti-
tated expression of BMP-2, BMP-7, and their receptors.
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